Predicting additional metastases in axillary lymph node dissection after neoadjuvant chemotherapy: Role of positive-to-total sentinel node ratio in cN1 patients scheduled for targeted axillary dissection
European Journal of Cancer · 2026-03 · 237 · 116485
DOI: 10.1016/j.ejca.2026.116485 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von I. Cebrecos und 5 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cebrecos, I., Torras, I., Quintas, L., Castillo, H., Abio, L., & Mension, E. (2026). Predicting additional metastases in axillary lymph node dissection after neoadjuvant chemotherapy: Role of positive-to-total sentinel node ratio in cN1 patients scheduled for targeted axillary dissection. European Journal of Cancer, 237, 116485. https://doi.org/10.1016/j.ejca.2026.116485
Vancouver
Cebrecos I, Torras I, Quintas L, Castillo H, Abio L, Mension E. Predicting additional metastases in axillary lymph node dissection after neoadjuvant chemotherapy: Role of positive-to-total sentinel node ratio in cN1 patients scheduled for targeted axillary dissection. European Journal of Cancer. 2026;237:116485. doi:10.1016/j.ejca.2026.116485
BibTeX
@article{Cebrecos2026,
author = {Cebrecos, I. and Torras, I. and Quintas, L. and Castillo, H. and Abio, L. and Mension, E.},
title = {Predicting additional metastases in axillary lymph node dissection after neoadjuvant chemotherapy: Role of positive-to-total sentinel node ratio in cN1 patients scheduled for targeted axillary dissection},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116485},
doi = {10.1016/j.ejca.2026.116485}
}
EUVIMED